An Act to amend the Financial Administration Act (borrowing of money)

This bill is from the 42nd Parliament, 1st session, which ended in September 2019.

Status

Dead, as of Sept. 27, 2016
(This bill did not become law.)

Summary

This is from the published bill.

This enactment amends Part IV (Public Debt) of the Financial
Administration Act to restrict the circumstances in which the Governor in Council may authorize the borrowing of money without legislative approval.

Similar bills

S-217 (41st Parliament, 1st session) An Act to amend the Financial Administration Act (borrowing of money)
S-229 (40th Parliament, 3rd session) An Act to amend the Financial Administration Act (borrowing of money)
S-221 (40th Parliament, 2nd session) An Act to amend the Financial Administration Act (borrowing of money)
S-236 (39th Parliament, 2nd session) An Act to amend the Financial Administration Act (borrowing of money)

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.

Bill numbers are reused for different bills each new session. Perhaps you were looking for one of these other S-204s:

S-204 (2021) Xinjiang Manufactured Goods Importation Prohibition Act
S-204 (2020) An Act to amend the Criminal Code and the Immigration and Refugee Protection Act (trafficking in human organs)
S-204 (2019) An Act to amend the Criminal Code and the Immigration and Refugee Protection Act (trafficking in human organs)
S-204 (2013) An Act to amend the Financial Administration Act (borrowing of money)
S-204 (2011) National Strategy for Chronic Cerebrospinal Venous Insufficiency (CCSVI) Act
S-204 (2010) An Act to amend the Criminal Code (protection of children)

Multiple SclerosisPetitionsRoutine Proceedings

November 18th, 2013 / 3:05 p.m.


See context

Liberal

Kirsty Duncan Liberal Etobicoke North, ON

Mr. Speaker, the debate concerning CCSVI should be based on science, evidence, and improving the quality of life for Canadians with MS, who wonder how the government is going to judge the radically different CCSVI data from the east and west of Canada.

Canadians with MS ask, if the debate had been based on evidence, why the Minister of Health did not meet with CCSVI groups across the country and with Canadians who had been treated to learn about their experience, why she did not include experts in CCSVI in her expert working group, and why the decision to kill Bill S-204 was taken eight months before the Senate hearings.

The petitioners are calling upon the minister to consult experts, to undertake Phase III clinical trials on an urgent basis, and to require follow-up care.